Parry Susan, Burt Randall W, Win Aung Ko, Aung Ye Kyaw, Woodall Sonja, Arnold Julie, Clendenning Mark, Buchanan Daniel D, Price Timothy J, Rosty Christophe, Young Joanne P
New Zealand Familial Gastrointestinal Cancer Service, Auckland City Hospital, Auckland.
Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA.
N Z Med J. 2017 Mar 3;130(1451):57-67.
Serrated polyposis syndrome (SPS) is associated with an increased risk of colorectal cancer (CRC) and an evolving management approach. The aims of this study were to assess the polyp burden reduction over time, and the incidence of CRC in serrated polyposis patients undergoing community surveillance.
This is an observational study based on prospectively collected data. A total of 96 SPS patients with no personal history of CRC were prospectively enrolled in a surveillance program under the guidance of a tertiary center. Patients underwent surveillance colonoscopy in multiple centres across New Zealand.
Patients underwent a median of four colonoscopies with a median interval of 15 months over a median follow-up period of 4.8 years. Five of 96 patients (5%) were referred for surgery, and the remaining 91 were managed by colonoscopy alone. In patients referred for surgery, 92% of the surveillance intervals to the fourth colonoscopy had been ≤12 months compared to 33% (P<0.001) in the colonoscopy only group, and all five (100%) had ≥20 pancolonic polyps after four procedures compared with only 5/91 (5%) in those managed by colonoscopy alone. In patients successfully managed by colonoscopy, 86% had <10 pancolonic polyps, >75% no longer had polyps ≥10mm and >90% no longer had proximal serrated polyps ≥10mm after the fourth colonoscopy. No patients were found to develop CRC during the study time period.
Patients with SPS were managed by proactive surveillance colonoscopy in wider hospital settings under tertiary centre guidance, with only 5% requiring surgical management. No CRC was diagnosed in any patient during surveillance.
锯齿状息肉病综合征(SPS)与结直肠癌(CRC)风险增加以及管理方法的不断演变相关。本研究的目的是评估随时间推移息肉负担的减轻情况,以及接受社区监测的锯齿状息肉病患者中结直肠癌的发病率。
这是一项基于前瞻性收集数据的观察性研究。共有96例无结直肠癌个人史的SPS患者在三级中心的指导下前瞻性纳入监测项目。患者在新西兰多个中心接受监测结肠镜检查。
患者在中位随访期4.8年期间,中位接受了4次结肠镜检查,中位间隔为15个月。96例患者中有5例(5%)被转诊进行手术,其余91例仅通过结肠镜检查进行管理。在转诊进行手术的患者中,至第四次结肠镜检查的监测间隔92%≤12个月,而仅接受结肠镜检查组为33%(P<0.001),并且在四次检查后,所有5例(100%)有≥20个全结肠息肉,而仅接受结肠镜检查管理的患者中只有5/91(5%)有。在通过结肠镜检查成功管理的患者中,86%在第四次结肠镜检查后全结肠息肉<10个,>75%不再有≥10mm的息肉,>90%不再有近端≥10mm的锯齿状息肉。在研究期间未发现患者发生结直肠癌。
SPS患者在三级中心指导下在更广泛的医院环境中通过积极的监测结肠镜检查进行管理,只有5%需要手术治疗。在监测期间未诊断出任何患者患有结直肠癌。